6.
Lopes M, Andrew T, Carbonaro F, Spector T, Hammond C
. Estimating heritability and shared environmental effects for refractive error in twin and family studies. Invest Ophthalmol Vis Sci. 2008; 50(1):126-31.
DOI: 10.1167/iovs.08-2385.
View
7.
Goldschmidt E, Jacobsen N
. Genetic and environmental effects on myopia development and progression. Eye (Lond). 2013; 28(2):126-33.
PMC: 3930266.
DOI: 10.1038/eye.2013.254.
View
8.
Avetisov S, Fisenko V, Zhuravlev A, Avetisov K
. [Atropine use for the prevention of myopia progression]. Vestn Oftalmol. 2018; 134(4):84-90.
DOI: 10.17116/oftalma201813404184.
View
9.
van der Sande E, Haarman A, Quint W, Tadema K, Meester-Smoor M, Kamermans M
. The Role of GJD2(Cx36) in Refractive Error Development. Invest Ophthalmol Vis Sci. 2022; 63(3):5.
PMC: 8934558.
DOI: 10.1167/iovs.63.3.5.
View
10.
Nuria V, Valldeflors V, Joan P, Alba G, Nuria T, Enric G
. Relationship between socioeconomic status and myopia in school children: CISViT project. J Optom. 2024; 17(4):100518.
PMC: 11331912.
DOI: 10.1016/j.optom.2024.100518.
View
11.
Torii H, Ohnuma K, Kurihara T, Tsubota K, Negishi K
. Violet Light Transmission is Related to Myopia Progression in Adult High Myopia. Sci Rep. 2017; 7(1):14523.
PMC: 5674003.
DOI: 10.1038/s41598-017-09388-7.
View
12.
Metlapally R, Wildsoet C
. Scleral Mechanisms Underlying Ocular Growth and Myopia. Prog Mol Biol Transl Sci. 2015; 134:241-8.
PMC: 4687967.
DOI: 10.1016/bs.pmbts.2015.05.005.
View
13.
Zhu Q, Tang Y, Guo L, Tighe S, Zhou Y, Zhang X
. Efficacy and Safety of 1% Atropine on Retardation of Moderate Myopia Progression in Chinese School Children. Int J Med Sci. 2020; 17(2):176-181.
PMC: 6990884.
DOI: 10.7150/ijms.39365.
View
14.
Nickla D, Wallman J
. The multifunctional choroid. Prog Retin Eye Res. 2010; 29(2):144-68.
PMC: 2913695.
DOI: 10.1016/j.preteyeres.2009.12.002.
View
15.
Wei S, Li S, An W, Du J, Liang X, Sun Y
. Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children: A Randomized Clinical Trial. JAMA Ophthalmol. 2020; 138(11):1178-1184.
PMC: 7530823.
DOI: 10.1001/jamaophthalmol.2020.3820.
View
16.
Yam J, Jiang Y, Tang S, Law A, Chan J, Wong E
. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control. Ophthalmology. 2018; 126(1):113-124.
DOI: 10.1016/j.ophtha.2018.05.029.
View
17.
Zadnik K, Schulman E, Flitcroft I, Fogt J, Blumenfeld L, Fong T
. Efficacy and Safety of 0.01% and 0.02% Atropine for the Treatment of Pediatric Myopia Progression Over 3 Years: A Randomized Clinical Trial. JAMA Ophthalmol. 2023; 141(10):990-999.
PMC: 10236322.
DOI: 10.1001/jamaophthalmol.2023.2097.
View
18.
Walline J, Jones L, Sinnott L
. Corneal reshaping and myopia progression. Br J Ophthalmol. 2009; 93(9):1181-5.
DOI: 10.1136/bjo.2008.151365.
View
19.
Tedja M, Wojciechowski R, Hysi P, Eriksson N, Furlotte N, Verhoeven V
. Genome-wide association meta-analysis highlights light-induced signaling as a driver for refractive error. Nat Genet. 2018; 50(6):834-848.
PMC: 5980758.
DOI: 10.1038/s41588-018-0127-7.
View
20.
Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutierrez-Ortega R
. Orthokeratology vs. spectacles: adverse events and discontinuations. Optom Vis Sci. 2012; 89(8):1133-9.
DOI: 10.1097/OPX.0b013e318263c5af.
View